Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Dodel

Showing results (21-30 of 250) with videos related to

Pageof 25
Sort By:
Ageing Research Reviews|November 6, 2021
Subjective cognitive decline in idiopathic Parkinson´s disease: A systematic reviewChristiane Oedekoven, Leonie Egeri, Frank Jessen, et al.
Journal of Nephrology|October 16, 2021
Assessment of cognitive impairment and related risk factors in hemodialysis patientsHristos Karakizlis, Katharina Bohl, Jannis Ziemek, et al.
Drugs|April 7, 2012
Economic evaluation of treatment options in patients with Alzheimer's disease: a systematic review of cost-effectiveness analysesLaura Pouryamout, Judith Dams, Juergen Wasem, et al.
Pharmacoeconomics|May 21, 2008
Cost of epilepsy: a systematic reviewAdam Strzelczyk, Jens Peter Reese, Richard Dodel, et al.
Neuroscience and Biobehavioral Reviews|October 28, 2009
APP transgenic mice: the effect of active and passive immunotherapy in cognitive tasksStephan Röskam, Frauke Neff, Rainer Schwarting, et al.
Oncology|September 16, 2008
Role of MIF in inflammation and tumorigenesisJan-Philipp Bach, Birgit Rinn, Bernhard Meyer, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 9, 2022
Alpha-synuclein Immunization Strategies for Synucleinopathies in Clinical Studies: A Biological PerspectiveLuisa Knecht, Jonas Folke, Richard Dodel, et al.
Journal of Geriatric Psychiatry and Neurology|January 1, 2010
Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD StudyOliver Riedel, Isabella Heuser, Jens Klotsche, et al.
CNS Drugs|September 16, 2008
Cost effectiveness of pharmacotherapies in early Parkinson's diseaseKarla M Eggert, Jens P Reese, Wolfgang H Oertel, et al.
European Neurology|January 30, 2009
Awareness and knowledge of the clinical practice guideline on Parkinson's disease among German neurologistsKarla Eggert, Astrid Larisch, Richard Dodel, et al.
Pageof 25

Showing results (21-30 of 250) with videos related to

Sort By:
Pageof 25
Ageing Research Reviews|November 6, 2021
Subjective cognitive decline in idiopathic Parkinson´s disease: A systematic reviewChristiane Oedekoven, Leonie Egeri, Frank Jessen, et al.
Journal of Nephrology|October 16, 2021
Assessment of cognitive impairment and related risk factors in hemodialysis patientsHristos Karakizlis, Katharina Bohl, Jannis Ziemek, et al.
Drugs|April 7, 2012
Economic evaluation of treatment options in patients with Alzheimer's disease: a systematic review of cost-effectiveness analysesLaura Pouryamout, Judith Dams, Juergen Wasem, et al.
Pharmacoeconomics|May 21, 2008
Cost of epilepsy: a systematic reviewAdam Strzelczyk, Jens Peter Reese, Richard Dodel, et al.
Neuroscience and Biobehavioral Reviews|October 28, 2009
APP transgenic mice: the effect of active and passive immunotherapy in cognitive tasksStephan Röskam, Frauke Neff, Rainer Schwarting, et al.
Oncology|September 16, 2008
Role of MIF in inflammation and tumorigenesisJan-Philipp Bach, Birgit Rinn, Bernhard Meyer, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 9, 2022
Alpha-synuclein Immunization Strategies for Synucleinopathies in Clinical Studies: A Biological PerspectiveLuisa Knecht, Jonas Folke, Richard Dodel, et al.
Journal of Geriatric Psychiatry and Neurology|January 1, 2010
Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD StudyOliver Riedel, Isabella Heuser, Jens Klotsche, et al.
CNS Drugs|September 16, 2008
Cost effectiveness of pharmacotherapies in early Parkinson's diseaseKarla M Eggert, Jens P Reese, Wolfgang H Oertel, et al.
European Neurology|January 30, 2009
Awareness and knowledge of the clinical practice guideline on Parkinson's disease among German neurologistsKarla Eggert, Astrid Larisch, Richard Dodel, et al.
Pageof 25